100 related articles for article (PubMed ID: 1418049)
1. Quantification of dechelation of gadopentetate dimeglumine in rats.
Kasokat T; Urich K
Arzneimittelforschung; 1992 Jun; 42(6):869-76. PubMed ID: 1418049
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging.
Schuhmann-Giampieri G; Frenzel T; Schmitt-Willich H
Arzneimittelforschung; 1993 Aug; 43(8):927-31. PubMed ID: 8216456
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and stability of caldiamide sodium in rats.
Okazaki O; Kurata T; Yoshioka N; Hakusui H
Arzneimittelforschung; 1996 Jan; 46(1):79-83. PubMed ID: 8821523
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats.
Tweedle MF; Wedeking P; Kumar K
Invest Radiol; 1995 Jun; 30(6):372-80. PubMed ID: 7490190
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the biodistribution of gadolinium-153 DTPA and technetium-99m DTPA in rats.
Prato FS; Wisenberg G; Marshall TP; Uksik P; Zabel P
J Nucl Med; 1988 Oct; 29(10):1683-7. PubMed ID: 3049959
[TBL] [Abstract][Full Text] [Related]
6. Whole-body autoradiographic studies in rats with gadolinium-diethylenetriaminepentaacetic acid, a new contrast agent for magnetic resonance imaging.
Täuber U; Weinmann HJ; Panzer M; Acksteiner B; Vollert B; Schulze PE
Arzneimittelforschung; 1986 Jul; 36(7):1089-91. PubMed ID: 3768078
[TBL] [Abstract][Full Text] [Related]
7. [A comparative study between Gd-BOPTA, a biliary excretion contrast medium, and Gd-DTPA in the magnetic resonance imaging of the rat liver].
Patrizio G; Pavone P; Cardone G; Pietroletti R; Passariello R; Tettamanti E; Musu C; Felder E
Radiol Med; 1990 May; 79(5):458-62. PubMed ID: 2359853
[TBL] [Abstract][Full Text] [Related]
8. Nonlinear pharmacokinetic modeling of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging.
Schuhmann-Giampieri G
Arzneimittelforschung; 1993 Sep; 43(9):1020-4. PubMed ID: 8240452
[TBL] [Abstract][Full Text] [Related]
9. Biodistribution and excretion of 153Gd-labeled gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid following repeated intravenous administration to rats.
Mühler A; Weinmann HJ
Acad Radiol; 1995 Apr; 2(4):313-8. PubMed ID: 9419568
[TBL] [Abstract][Full Text] [Related]
10. A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media.
Sieber MA; Pietsch H; Walter J; Haider W; Frenzel T; Weinmann HJ
Invest Radiol; 2008 Jan; 43(1):65-75. PubMed ID: 18097279
[TBL] [Abstract][Full Text] [Related]
11. Blood-retinal barrier breakdown investigated by real-time magnetic resonance imaging after gadolinium-diethylenetriaminepentaacetic acid injection.
Berkowitz BA; Sato Y; Wilson CA; de Juan E
Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):2854-60. PubMed ID: 1917389
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of gadoxetate disodium as a contrast agent for mouse liver imaging: comparison with gadobenate dimeglumine.
Kiryu S; Inoue Y; Watanabe M; Izawa K; Shimada M; Tojo A; Yoshikawa K; Ohtomo K
Magn Reson Imaging; 2009 Jan; 27(1):101-7. PubMed ID: 18599243
[TBL] [Abstract][Full Text] [Related]
13. Lanthanide chelates of (bis)-hydroxymethyl-substituted DTTA with potential application as contrast agents in magnetic resonance imaging.
Silvério S; Torres S; Martins AF; Martins JA; André JP; Helm L; Prata MI; Santos AC; Geraldes CF
Dalton Trans; 2009 Jun; (24):4656-70. PubMed ID: 19513474
[TBL] [Abstract][Full Text] [Related]
14. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging.
Kunimasa J; Inui K; Hori R; Kawamura Y; Endo K
Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380
[TBL] [Abstract][Full Text] [Related]
15. Blood-brain barrier injury following intracarotid injection of radiographic contrast media. In vivo quantification using magnetic resonance imaging and Gd-DTPA.
Hayakawa K; Yamashita K; Mitsumori M; Nakano Y
Acta Radiol; 1990 Mar; 31(2):203-8. PubMed ID: 2372465
[TBL] [Abstract][Full Text] [Related]
16. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
Bauner KU; Reiser MF; Huber AM
Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
[TBL] [Abstract][Full Text] [Related]
17. Quantitative magnetic resonance imaging in assessment of the blood-retinal barrier.
Plehwe WE; McRobbie DW; Lerski RA; Kohner EM
Invest Ophthalmol Vis Sci; 1988 May; 29(5):663-70. PubMed ID: 3366561
[TBL] [Abstract][Full Text] [Related]
18. Gadolinium-DTPA transplacental transfer and distribution in fetal tissue in rabbits.
Novak Z; Thurmond AS; Ross PL; Jones MK; Thornburg KL; Katzberg RW
Invest Radiol; 1993 Sep; 28(9):828-30. PubMed ID: 8225889
[TBL] [Abstract][Full Text] [Related]
19. The relaxivity of Gd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat.
Shuter B; Tofts PS; Wang SC; Pope JM
Magn Reson Imaging; 1996; 14(3):243-53. PubMed ID: 8725190
[TBL] [Abstract][Full Text] [Related]
20. Gd-DOTA: characterization of a new paramagnetic complex.
Bousquet JC; Saini S; Stark DD; Hahn PF; Nigam M; Wittenberg J; Ferrucci JT
Radiology; 1988 Mar; 166(3):693-8. PubMed ID: 3340763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
